Zang R, Gomez Castro MF, McCune BT, et al. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci Immunol. 2020;5:eabc3582.
Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203:631–7.
Elhence A. Shalimar. COVID-19: beyond respiratory tract. J Dig Endosc. 2020;11:24–6.
Ghoshal UC, Ghoshal U, Mathur A, et al. The spectrum of gastrointestinal symptoms in patients with coronavirus disease-19: predictors, relationship with disease severity, and outcome. Clin Transl Gastroenterol. 2020;11:e00259.
Ghoshal UC, Ghoshal U, Dhiman RK. Gastrointestinal and hepatic involvement in severe acute respiratory syndrome coronavirus 2 infection: a review. J Clin Exp Hepatol. 2020;10:622–8.
Chaugale SB, Singhal V, Kapoor D, Singh A. Gastrointestinal complications (gangrene or perforation) after corona virus disease 2019 - a series of ten patients. Indian J Gastroenterol. 2022; 41: https://doi.org/10.1007/s12664-021-01218-z.
Hashim Z, Jaiswal S, Mohindra S. Thrombosis leading to acute abdomen in coronavirus disease 2019: a case series. Indian J Gastroenterol. 2022; 41. https://doi.org/10.1007/s12664-022-01260-5.
El Moheb M, Naar L, Christensen MA, et al. Gastrointestinal complications in critically ill patients with and without COVID-19. JAMA. 2020;324:1899–901.
Bhayana R, Som A, Li MD, et al. Abdominal imaging findings in COVID-19: preliminary observations. Radiology. 2020;297:E207–15.
Goldberg-Stein S, Fink A, Paroder V, Kobi M, Yee J, Chernyak V. Abdominopelvic CT findings in patients with novel coronavirus disease 2019 (COVID-19). Abdom Radiol (NY). 2020;45:2613–23.
O'Shea A, Parakh A, Hedgire S, Lee SI. Multisystem assessment of the imaging manifestations of coagulopathy in hospitalized patients with coronavirus disease (COVID-19). AJR Am J Roentgenol. 2021;216:1088–98.
Shiralkar K, Chinapuvvula N, Ocazionez D. Cross-sectional abdominal imaging findings in patients with COVID-19. Cureus [Internet]. Cureus; 2020 [cited 2022 Mar 20];12. Available from: https://www.cureus.com/articles/35834-cross-sectional-abdominal-imaging-findings-in-patients-with-covid-19
Norsa L, Bonaffini PA, Indriolo A, Valle C, Sonzogni A, Sironi S. Poor outcome of intestinal ischemic manifestations of COVID-19. Gastroenterology. 2020;159:1595–7.e1.
Serban D, Tribus LC, Vancea G, et al. Acute mesenteric ischemia in COVID-19 patients. J Clin Med. 2021;11:200.
Estevez-Cerda SC, Saldaña-Rodríguez JA, Alam-Gidi AG, et al. Severe bowel complications in SARS-CoV-2 patients receiving protocolized care. Rev Gastroenterol Mex (Engl Ed). 2021;86:378–86.
Kaafarani HMA, El Moheb M, Hwabejire JO, et al. Gastrointestinal complications in critically ill patients with COVID-19. Ann Surg. 2020;272:e61–2.
Leentjens J, van Haaps TF, Wessels PF, Schutgens REG, Middeldorp S. COVID-19-associated coagulopathy and antithrombotic agents-lessons after 1 year. Lancet Haematol. 2021;8:e524–33.
Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19.Lancet. 2020;395:1417–8.
Parry AH, Wani AH, Yaseen M. Acute mesenteric ischemia in severe coronavirus-19 (COVID-19): Possible mechanisms and diagnostic pathway. Acad Radiol. 2020;27:1190.
Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18:1738–42.
Jose RJ, Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med. 2020;8:e46–7.
RECOVERY Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with COVID-19. N Engl J Med. 2021;384:693–704.
Soin AS, Kumar K, Choudhary NS, et al. Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial. Lancet Respir Med. 2021;9:511–21.
Fadul CE, Lemann W, Thaler HT, Posner JB. Perforation of the gastrointestinal tract in patients receiving steroids for neurologic disease. Neurology. 1988;38:348–52.
Arsura EL. Corticosteroid-association perforation of colonic diverticula. Arch Intern Med. 1990;150:1337–8.
Saad E, Awadelkarim A, Agab M, Babkir A. Tocilizumab-associated small bowel perforation in a young patient with rheumatoid arthritis: a lesson to remember during COVID-19 pandemic. J Med Cases. 2022;13:135–9.
Bulte JP, Postma N, Beukema M, et al. COVID 19 and the risk of gastro-intestinal perforation: a case series and literature review. J Crit Care. 2022;67:100–3.
Baricitinib: Drug information - UpToDate [Internet]. [cited 2022 Mar 23]. Available from: https://www.uptodate.com/contents/baricitinib-drug-information. Accessed 23 March 2022
Hwabejire JO, Kaafarani HMA, Mashbari H, et al. Bowel ischemia in COVID-19 infection: one-year surgical experience. Am Surg. 2021;87:1893–900.
Gupta A, Sharma O, Srikanth K, Mishra R, Tandon A, Rajput D. Review of mesenteric ischemia in COVID-19 patients. Indian J Surg [Internet]. 2022 [cited 2022 Mar 20]; Available from: https://doi.org/10.1007/s12262-022-03364-w.
Ojha V, Mani A, Mukherjee A, Kumar S, Jagia P. Mesenteric ischemia in patients with COVID-19: an updated systematic review of abdominal CT findings in 75 patients. Abdom Radiol [Internet]. 2021 [cited 2022 Mar 20]; Available from: https://link.springer.com/10.1007/s00261-021-03337-9